Skip to main content
Clinical Trials/NCT05244525
NCT05244525CompletedPhase 4

Subacromial Injection of Epinephrine Improves Visualization in Shoulder Arthroscopy

The University of Texas Health Science Center, Houston1 site in 1 country60 target enrollmentStarted: March 14, 2022Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Surgeon-rated Visual Clarity as Assessed by the Visual Analog Scale

Study Overview

Brief Summary

The purpose of this study is to evaluate surgeon-rated visual clarity and the need for increased irrigation pump pressure during arthroscopic shoulder surgery and to evaluate mean arterial pressure, operative time, and any adverse events that occur during arthroscopic shoulder surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Undergo arthroscopic shoulder surgery in the seated upright (beach-chair) position requiring visualization within the subacromial space

Exclusion Criteria

  • Are unable to provide informed consent
  • Non-English speaker
  • Have a history of adverse medication reaction to epinephrine

Arms & Interventions

Treatment

Experimental

Intervention: Bupivacaine with Epinephrine (Drug)

Control Group

Active Comparator

Intervention: Bupivacaine alone (Drug)

Outcomes

Primary Outcomes

Surgeon-rated Visual Clarity as Assessed by the Visual Analog Scale

Time Frame: end of surgery(about 30-120 minutes from start of surgery)

This scale is scored from 1-10, a higher number indicating better clarity

Percentage of Participants for Whom Intra-operative Arthroscopic Pump Pressure Was Increased to 45mmHg or Higher During the Surgical Procedure

Time Frame: From start of surgery to end of surgery(about 30-120 minutes)

The pump pressure is initially set at 35mmHg during the arthroscopic surgical procedure. If visualization is limited during the procedure, surgeons may increase the pump pressure of arthroscopic fluid within the shoulder during the procedure. This outcome measure reports the percentage of participants for whom intra-operative arthroscopic pump pressure was increased to 45mmHg or higher during the surgical procedure.

Secondary Outcomes

  • Intraoperative Mean Arterial Pressure(end of surgery(about 30-120 minutes from start of surgery))
  • Number of Subjects Who Experience Intraoperative Adverse Events(end of surgery(about 30-120 minutes from start of surgery))
  • Total Operative Time(end of surgery(about 30-120 minutes from start of surgery))
  • Number of Subjects Who Experience Post Operative Adverse Events(from the end of surgery up to 2 weeks post surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

James M. Gregory

Associate Professor

The University of Texas Health Science Center, Houston

Study Sites (1)

Loading locations...

Similar Trials